Dr. Reddy's Laboratories Ltd. closed 21.99% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...

Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...

The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...

Dr. Reddy's Laboratories Ltd. closed 22.18% short of its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...

Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...

Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

In this article, we are going to take a look at where Dr. Reddy's Laboratories Limited (NYSE:RDY) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer ...

The stock market experienced declines on March 12, with Dr. Reddy’s Laboratories and others reaching yearly lows due to US ...

Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.